Global airline Delta Air Lines (NYSE:DAL) will be reporting results this Tuesday morning. Here’s what you need to know.

The Cboe Volatility Index, also known as Wall Street’s fear gauge, fell 5.6% Monday to a 12-month low. The benchmark ended the day at 14.08, its lowest closing value since Dec. 13, 2024, according to ...

The U.S. stock market is poised to be kept on edge next year as investors are caught between fear of missing out on the artificial-intelligence rally and concern that it’s a bubble just waiting to ...

IV spikes hint at traders to anticipate an IV crush With the new year approaching, many traders are reassessing their strategies and preparing for market conditions ahead. While implied volatility (IV ...

Wall Street worrywarts have gone back into hiding as peace breaks out across markets. Just weeks ago, fears mounted with every speculative swing. Crypto plunged. AI stocks surged, then reversed.

The rising volatility suggests a potential return to levels seen before the launch of BTC exchange-traded funds, which dampened volatility. Bitcoin’s (BTC) price volatility has surged over the last ...

After a volatile October, traders expect options activity and market turbulence to intensify heading into year-end. Several factors are feeding the uptick in volatility: large stock swings following ...

What Issues Do Clients Bring to Advisors? What Issues Do Clients Bring to Advisors? What May Clients Not Think to Ask About? Tactics for Advisors to Use Better Manage Market Volatility No advisor ...

Crypto moves fast. Here’s how to keep your balance when prices swing. Nathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency, ETFs, ...

Bitcoin’s BTC $91,638.77 key volatility index remains elevated even as the S&P 500 VIX index, Wall Street's primary fear gauge, has eased from its surge following the Oct. 10 market shakeup. Observers ...

Forbes contributors publish independent expert analyses and insights. I cover the intersection of people, risk, leadership and performance. As business leaders and boards set their sights on 2026 ...

The MarketWatch News Department was not involved in the creation of this content. -- Presentation highlights novel TLR7/8 co-agonist in combination with pembrolizumab and chemotherapy in late-stage ...